MBL International and SCIVAX USA Open Their First U.S. R&D Laboratory in Woburn, MA

June 12, 2014

Japanese Companies Partner on New Wet Lab Facilities

Woburn, MA — (June 12, 2014) — MBL International Corporation, a leading life science company focused on providing high quality, innovative, solutions-based products for both life science research and clinical diagnostics, and SCIVAX USA, INC., a leading provider of 3D cell culture solutions based on the original “Micro-Patterned Surface Technology,” are delighted to announce the official opening of a new shared laboratory in Woburn, Massachusetts, an emerging life science innovation district in the Greater Boston area. MBL International Corporation and SCIVAX USA, INC. hosted a ribbon-cutting ceremony today to mark the opening of their new facility. The ceremony was held in collaboration with the Massachusetts Life Sciences Center (MLSC) and MassBio. A number of industry and government officials participated, including the Consul General of Japan in Boston.

“Massachusetts leads the world in life sciences thanks to our growth strategy of investing in education, innovation and infrastructure, and looking out into the global economy, not just in,” said Governor Deval Patrick. “We look forward to working with Scivax USA and MBL International as they open their first U.S. laboratory facility here in the Commonwealth.”

“The lab represents a new chapter in the development of MBL International and SCIVAX USA. Our researchers now have the facilities and resources to extend both company’s research and development support capabilities,” said Kimimasa Yamada, CEO of MBL International Corporation.

“The lab is not only enhancing the R&D capabilities of both companies, but is also expected to become a frontline base for the innovative collaborators of both companies in Japan, to enter the U.S. market,” said Hiromi Miura, President of SCIVAX USA.

The 3,000 square-foot immunological and molecular biological R&D facility houses both MBL International and SCIVAX USA’s state-of-the art imaging equipment, including a GE InCell2200 and Flow Cytometer. In addition to imaging instrumentation, the facility is outfitted with a cell culture capability focused on novel three-dimensional cell culture technology.

“On behalf of the team at the Massachusetts Life Sciences Center, congratulations to Scivax USA and MBL International on the opening of their first U.S. wet laboratory,” said Susan Windham-Bannister, Ph.D., President & CEO of the MLSC. “The expanded presence of these companies in Massachusetts will enhance our life sciences ecosystem, and further strengthen the growing business ties between Massachusetts and Japan.”

“We are very pleased that our growing business relationship with Japan is continuing to bear fruit, a relationship that was further developed through the recent Governor led trade mission to the region,” said Richard Elam, Executive Director of the Massachusetts Office of International Trade & Investment. “From the two recent MOU signings between the Commonwealth and Japan’s Kanagawa Prefecture and the Japanese External Trade Organization to today’s announcement of the Scivax/MBL establishment in Massachusetts, we are seeing a significant increase in the already vibrant economic relationship between Massachusetts and Japan.”

MBL International was established in a suburb of Boston in 1993 and has since been a leading life science company focused on providing high quality, innovative, solution-based products for both life science research and clinical diagnostics in North America, South America, Europe and other countries. In the field of life science research, the Company sells distinct antibodies and biological reagents in high demand by researchers. MBLI has recently started manufacturing and selling globally MHC Tetramer products which can detect antigen-specific T cells. In the epigenomic area, the Company also plans to launch new antibodies which recognize characteristic modified nucleic acids. Regarding in vitro diagnostics, MBLI sells indirect immunofluorescence products for autoimmune and infectious diseases and ELISA products for autoimmune disease.

SCIVAX USA opened their sales office in Woburn, MA in October 2010, and has steadily increased the sales of their 3D cell culture ware “NanoCulture Plate” in the U.S. market. The opening of this new laboratory facility is expected to add assay development and contract research capabilities to the company, which is expected to accelerate its growth and presence in the life science market.
MBL International and SCIVAX USA’s new facility is located at the following address:

3-G Gill Street
Woburn, MA 01801
Phone: 781-281-2985 for MBL International,
Phone: 781-281-2997 for SCIVAX USA
Email: kyamada@mblintl.com
Email: h-miura@scivax.com

About MBL International Corporation (MBLI)

MBLI, headquartered in Woburn, MA, was established in 1993 as a wholly owned subsidiary of Medical & Biological Laboratories, Co., Ltd. The company has provided research reagents in life science and clinical diagnostic products manufactured by MBL to the USA and Europe. Through the acquisition of Bion Enterprises, Ltd. in 2008, MBLI expanded its diagnostic portfolio to include immunofluorescence assay products, further strengthening its autoimmune and infectious disease product offering. MBLI licensed the entire portfolio of MHC tetramer products from Beckman Coulter in 2013, and started selling the products in the USA and Europe. MBLI’s sales territories include North America, Europe, Central America, South America, and the Middle East through India. For more information, please visit http://www.mblintl.com/.


SCIVAX USA, INC. headquartered in Woburn, MA, USA, is a leading 3D cell culture technology company, with the original Micro-Patterned Surface technology based 3D cell culture ware “NanoCulture Plate (NCP)”. NCP enables to culture in vivo like 3D multi-cellular spheroids easily, using the same technique for monolayer cell culture. Its “Minimal-Attachment” concept gives in vivo like anchorage-independence growth environment to the spheroids formed, and its capability is highly valued by both pharmaceutical companies and academic institutes, with growing users in Japan, USA and Europe. SCIVAX USA is a 100% owned subsidiary of SCIVAX Life Sciences, Inc., which is a 100% owned subsidiary of JSR Corporation, a leading Japanese synthetic rubber and plastic manufacturing company, who owns diversified business fields including semiconductor and life sciences.
For more information, visit http://www.scivax.com/usa/

About the Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.